Herein, the expression levels of IL1RN were restored to near normal levels in HL rats which administered both MSCs-Exo+EVOO indicating their combined beneficial role for mitigating NAFLD/NASH progression in our study rats. The gene discussed is IL1RN; the disease is metabolic dysfunction-associated steatotic liver disease.